vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Custom Truck One Source, Inc. (CTOS). Click either name above to swap in a different company.

Custom Truck One Source, Inc. is the larger business by last-quarter revenue ($422.2M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -4.2%, a 100.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -8.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 14.8%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Custom Truck One Source, Inc. is a leading provider of specialized heavy truck and equipment solutions in North America. It offers custom vehicle manufacturing, equipment sales and rentals, aftermarket parts, and maintenance services, serving core infrastructure, utility, construction, and energy industry segments.

ACAD vs CTOS — Head-to-Head

Bigger by revenue
CTOS
CTOS
1.5× larger
CTOS
$422.2M
$284.0M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+17.9% gap
ACAD
9.4%
-8.5%
CTOS
Higher net margin
ACAD
ACAD
100.5% more per $
ACAD
96.3%
-4.2%
CTOS
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
14.8%
CTOS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACAD
ACAD
CTOS
CTOS
Revenue
$284.0M
$422.2M
Net Profit
$273.6M
$-17.8M
Gross Margin
90.8%
20.3%
Operating Margin
6.1%
2.9%
Net Margin
96.3%
-4.2%
Revenue YoY
9.4%
-8.5%
Net Profit YoY
90.3%
-333.7%
EPS (diluted)
$1.61
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
CTOS
CTOS
Q1 26
$422.2M
Q4 25
$284.0M
$387.3M
Q3 25
$278.6M
$359.9M
Q2 25
$264.6M
$392.2M
Q1 25
$244.3M
$307.1M
Q4 24
$259.6M
$398.3M
Q3 24
$250.4M
$337.5M
Q2 24
$242.0M
$320.6M
Net Profit
ACAD
ACAD
CTOS
CTOS
Q1 26
$-17.8M
Q4 25
$273.6M
$20.9M
Q3 25
$71.8M
$-5.8M
Q2 25
$26.7M
$-28.4M
Q1 25
$19.0M
$-17.8M
Q4 24
$143.7M
$27.6M
Q3 24
$32.8M
$-17.4M
Q2 24
$33.4M
$-24.5M
Gross Margin
ACAD
ACAD
CTOS
CTOS
Q1 26
20.3%
Q4 25
90.8%
31.8%
Q3 25
92.2%
28.0%
Q2 25
92.2%
26.1%
Q1 25
91.7%
27.9%
Q4 24
91.6%
29.7%
Q3 24
92.5%
27.2%
Q2 24
92.5%
27.8%
Operating Margin
ACAD
ACAD
CTOS
CTOS
Q1 26
2.9%
Q4 25
6.1%
13.4%
Q3 25
12.8%
9.1%
Q2 25
12.2%
7.1%
Q1 25
7.9%
4.0%
Q4 24
59.1%
16.9%
Q3 24
12.6%
6.8%
Q2 24
12.6%
5.5%
Net Margin
ACAD
ACAD
CTOS
CTOS
Q1 26
-4.2%
Q4 25
96.3%
5.4%
Q3 25
25.8%
-1.6%
Q2 25
10.1%
-7.2%
Q1 25
7.8%
-5.8%
Q4 24
55.4%
6.9%
Q3 24
13.1%
-5.2%
Q2 24
13.8%
-7.6%
EPS (diluted)
ACAD
ACAD
CTOS
CTOS
Q1 26
$-0.08
Q4 25
$1.61
$0.10
Q3 25
$0.42
$-0.03
Q2 25
$0.16
$-0.13
Q1 25
$0.11
$-0.08
Q4 24
$0.86
$0.11
Q3 24
$0.20
$-0.07
Q2 24
$0.20
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
CTOS
CTOS
Cash + ST InvestmentsLiquidity on hand
$177.7M
$6.3M
Total DebtLower is stronger
$25.9M
Stockholders' EquityBook value
$1.2B
$809.1M
Total Assets
$1.6B
$3.4B
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
CTOS
CTOS
Q1 26
$6.3M
Q4 25
$177.7M
$6.3M
Q3 25
$258.0M
$13.1M
Q2 25
$253.6M
$5.3M
Q1 25
$217.7M
$5.4M
Q4 24
$319.6M
$3.8M
Q3 24
$155.1M
$8.4M
Q2 24
$177.1M
$8.1M
Total Debt
ACAD
ACAD
CTOS
CTOS
Q1 26
$25.9M
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
Stockholders' Equity
ACAD
ACAD
CTOS
CTOS
Q1 26
$809.1M
Q4 25
$1.2B
$809.1M
Q3 25
$917.3M
$784.7M
Q2 25
$822.4M
$790.1M
Q1 25
$765.2M
$813.4M
Q4 24
$732.8M
$861.3M
Q3 24
$577.2M
$837.5M
Q2 24
$516.7M
$856.7M
Total Assets
ACAD
ACAD
CTOS
CTOS
Q1 26
$3.4B
Q4 25
$1.6B
$3.4B
Q3 25
$1.3B
$3.5B
Q2 25
$1.2B
$3.6B
Q1 25
$1.1B
$3.5B
Q4 24
$1.2B
$3.5B
Q3 24
$976.9M
$3.6B
Q2 24
$914.1M
$3.5B
Debt / Equity
ACAD
ACAD
CTOS
CTOS
Q1 26
0.03×
Q4 25
2.03×
Q3 25
2.10×
Q2 25
2.04×
Q1 25
1.97×
Q4 24
1.77×
Q3 24
1.87×
Q2 24
1.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
CTOS
CTOS
Operating Cash FlowLast quarter
$-48.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.18×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
CTOS
CTOS
Q1 26
Q4 25
$-48.7M
$47.3M
Q3 25
$74.3M
$81.5M
Q2 25
$64.0M
$125.7M
Q1 25
$20.3M
$55.6M
Q4 24
$40.4M
$82.1M
Q3 24
$63.2M
$16.5M
Q2 24
$25.0M
$37.8M
Free Cash Flow
ACAD
ACAD
CTOS
CTOS
Q1 26
Q4 25
Q3 25
$73.9M
Q2 25
Q1 25
Q4 24
Q3 24
$63.2M
Q2 24
FCF Margin
ACAD
ACAD
CTOS
CTOS
Q1 26
Q4 25
Q3 25
26.5%
Q2 25
Q1 25
Q4 24
Q3 24
25.2%
Q2 24
Capex Intensity
ACAD
ACAD
CTOS
CTOS
Q1 26
Q4 25
Q3 25
0.1%
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Cash Conversion
ACAD
ACAD
CTOS
CTOS
Q1 26
Q4 25
-0.18×
2.27×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
2.98×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

CTOS
CTOS

Equipment sales$273.9M65%
Rental revenue$116.3M28%
Parts sales and services$32.1M8%

Related Comparisons